Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial

Andreas Stahl; Matthias Bolz

doi:10.1001/jama.2022.10564

Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial

Department of Ophthalmology and Optometry

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	349-359
Number of pages	12
Journal	JAMA Ophthalmology
DOIs	https://doi.org/10.1001/jama.2022.10564
Publication status	Published - Jul 2022

Fields of science

302007 Ophthalmology

Access to Document

10.1001/jama.2022.10564

Cite this

@article{8e779bc78b1e4d27adf62c99947ff47f,

title = "Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial",

author = "Andreas Stahl and Matthias Bolz",

year = "2022",

month = jul,

doi = "10.1001/jama.2022.10564",

language = "English",

pages = "349--359",

journal = "JAMA Ophthalmology",

issn = "2168-6165",

publisher = "AMER MEDICAL ASSOC, 330 N WABASH AVE, STE 39300, CHICAGO, USA, IL, 60611-5885",

}

TY - JOUR

T1 - Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial

AU - Stahl, Andreas

AU - Bolz, Matthias

PY - 2022/7

Y1 - 2022/7

U2 - 10.1001/jama.2022.10564

DO - 10.1001/jama.2022.10564

M3 - Article

SN - 2168-6165

SP - 349

EP - 359

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

ER -